Back to results
US 2024/0248094 A1Published application
Ultra bright dimeric or polymeric dyes with spacing linker groups
AssigneeSony Group Corporation
InventorsTracy MATRAY, Sharat SINGH
Life of this patent
Estimating the term…
Abstract
Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): or a stercoisomer, tantomer or salt thereof, wherein R1, R2, R3, R4, R5, L1, L2, L3, L4, M, m and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.
Claims20
A method, comprising:
- admixing a compound, or a stereoisomer, salt or tautomer thereof, with an antibody, the compound having the following structure (I):
- wherein:
- M is, at each occurrence, independently a fluorescent dye;
- L′ is at each occurrence, independently either:
- i) an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;
- or ii) a linker comprising a functional group capable of formation by reaction of two complementary reactive groups;
- L2 and L3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;
- L4 is, at each occurrence, independently a polyethylene oxide linker;
- R1 is, at each occurrence, independently H, alkyl or alkoxy;
- R2 and R3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═Ra)(Rb)Rc, Q, or a protected form thereof, or L′;
- R4 is, at each occurrence, independently OH, SH, O—, S—, ORa or SRa;
- R5 is, at each occurrence, independently oxo, thioxo or absent;
- Ra is O or S;
- Rb is OH, SH, O—, S—, ORa or SRa;
- Rc is OH, SH, O−, S−, ORa, OL′, SRa, alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;
- Rd is a counter ion;
- Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with the antibody;
- L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to the antibody;
- m is, at each occurrence, independently an integer of one or greater;
- and
- n is an integer of one or greater,
- provided that at least one occurrence of either R2 and R3 is —OP(═Ra)(Rb)Rc, Q, or a protected form thereof, or L′, wherein Rc is OL′;
- and
- forming a conjugate of the first compound to the antibody.
21 more elements
A method for preparing a conjugate of a compound, comprising:
- admixing a compound or a stereoisomer, salt or tautomer thereof, with an antibody, wherein the compound is conjugated to a sulfur atom of the antibody, and wherein the first compound has the following structure (I):
- wherein:
- M is, at each occurrence, independently a fluorescent dye;
- L′ is at each occurrence, independently either:
- i) an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;
- or ii) a linker comprising a functional group capable of formation by reaction of two complementary reactive groups;
- L2 and L3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;
- L4 is, at each occurrence, independently a polyethylene oxide linker;
- R1 is, at each occurrence, independently H, alkyl or alkoxy;
- R2 and R3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═Ra)(Rb)Rc, Q, or a protected form thereof, or L′;
- R4 is, at each occurrence, independently OH, SH, O—, S—, ORd or SRd;
- R5 is, at each occurrence, independently oxo, thioxo or absent;
- Ra is O or S;
- Rb is OH, SH, O, S—, ORd or SRd;
- Rc is OH, SH, O, S—, ORd, OL′, SRd, alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;
- Ra is a counter ion;
- Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with the antibody;
- L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to the antibody;
- m is, at each occurrence, independently an integer of one or greater, and
- n is an integer of one or greater,
- provided that at least one occurrence of either R2 and R3 is —OP(═Ra)(Rs)Rc, Q, or a protected form thereof, or L′, wherein Rc is OL′.
18 more elements
A method of conjugating a polymeric dye compound to an analyte or targeting moiety, comprising:
- admixing the polymeric dye compound, or a stereoisomer, salt or tautomer thereof, with the analyte or targeting moiety having specificity for the analyte, wherein the dye compound is conjugated to a sulfur atom of the analyte or targeting moiety, and wherein the polymeric dye compound has the following structure of (I):
- wherein:
- M is, at each occurrence, independently a fluorescent dye;
- L′ is at each occurrence, independently either:
- i) an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;
- or ii) a linker comprising a functional group capable of formation by reaction of two complementary reactive groups;
- L2 and L3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;
- L4 is, at each occurrence, independently a polyethylene oxide linker;
- R1 is, at each occurrence, independently H, alkyl or alkoxy;
- R2 and R3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═Ra)(Rb)Rc, Q, or a protected form thereof, or L′;
- R4 is, at each occurrence, independently OH, SH, O—, S—, ORd or SRd;
- R5 is, at each occurrence, independently oxo, thioxo or absent;
- Ra is O or S;
- Rb is OH, SH, O—, S—, ORd or SRd;
- Rc is OH, SH, O—, S—, ORd, OL′, SRd, alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;
- Rd is a counter ion;
- Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with the analyte or targeting moiety;
- L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to the analyte or targeting moiety;
- m is, at each occurrence, independently an integer of one or greater;
- and
- n is an integer of one or greater,
- provided that at least one occurrence of either R2 and R3 is —OP(═Ra)(Rb)Rc, Q, or a protected form thereof, or L′, wherein Rc is OL′.
19 more elements
Dependencies are inferred from the claim text.